Sharps Technology Inc. (STSSW)
0.02
0.01 (102.02%)
At close: Apr 01, 2025, 3:59 PM
Company Description
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.
It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.
The company was incorporated in 2017 and is based in Melville, New York.
Sharps Technology Inc.
| Country | United States |
| IPO Date | Apr 14, 2022 |
| Industry | Financial - Capital Markets |
| Sector | Financial Services |
| Employees | 57 |
| CEO | Robert M. Hayes |
Contact Details
Address: 105 Maxess Road Melville, New York United States | |
| Website | https://sharpstechnology.com |
Stock Details
| Ticker Symbol | STSSW |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F119 |
| ISIN Number | US82003F1194 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer & Director |
| Andrew R. Crescenzo CPA | Chief Financial Officer |
| Ben Scheu | Senior Director of Sales |
| Frank Parrado | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 8-K | Current Report |
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 20, 2025 | DEFA14A | Filing |
| Mar 20, 2025 | 8-K | Current Report |
| Mar 14, 2025 | 8-K | Current Report |
| Feb 11, 2025 | DEF 14A | Filing |
| Feb 05, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | AW | Filing |
| Jan 31, 2025 | PRE 14A | Filing |